Literature DB >> 20030697

Anxiety and depression in cancer patients compared with the general population.

A Hinz1, O Krauss, J P Hauss, M Höckel, R D Kortmann, J U Stolzenburg, R Schwarz.   

Abstract

The objective of this study was to compare the prevalence of anxiety and depression in cancer patients with the prevalence found in the general population, using the Hospital Anxiety and Depression Scale (HADS). Participants were 1529 cancer patients treated between 2002 and 2004 in Germany and 2037 persons from the German general population. In the cancer patients, the risk of psychiatric distress was nearly twice that of the general population. While for older age groups (61 years and above) there were only small differences between cancer patients and the general population, the differences in both scales were high for young persons. There were differences between the HADS mean scores of the patients with different tumour localisations, with high values for brain cancer and low scores for prostate cancer. The influence of the tumour stage on anxiety and depression was weak. However, depression scores of patients with a survival time less than 1 year were elevated. The results show that large sample sizes are necessary to evaluate the psychological situation of cancer patients, and that age and gender differences must be taken into account when several samples are compared.

Entities:  

Mesh:

Year:  2009        PMID: 20030697     DOI: 10.1111/j.1365-2354.2009.01088.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  58 in total

1.  Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin's lymphoma: a cohort study of the French national health insurance database.

Authors:  Cécile Conte; Manuela Rueter; Guy Laurent; Robert Bourrel; Maryse Lapeyre-Mestre; Fabien Despas
Journal:  Support Care Cancer       Date:  2016-07-19       Impact factor: 3.603

2.  The benefits of psychosocial interventions for cancer patients undergoing radiotherapy.

Authors:  Zhen Guo; Hua-Ying Tang; Hao Li; Sheng-Kui Tan; Kai-Hua Feng; Yin-Chun Huang; Qing Bu; Wei Jiang
Journal:  Health Qual Life Outcomes       Date:  2013-07-17       Impact factor: 3.186

3.  Exercise-based oncology rehabilitation: leveraging the cardiac rehabilitation model.

Authors:  Kim L Dittus; Susan G Lakoski; Patrick D Savage; Nathan Kokinda; Michael Toth; Diane Stevens; Kimberly Woods; Patricia OʼBrien; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 Mar-Apr       Impact factor: 2.081

4.  Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy.

Authors:  Shu-Long Jiang; Hong-Jie Liu; Zhao-Chun Liu; Ning Liu; Rui Liu; Young-Reep Kang; Joong-Gu Ji; Chao Zhang; Bao-Jin Hua; Shin-Jyung Kang
Journal:  Chin J Integr Med       Date:  2015-07-04       Impact factor: 1.978

Review 5.  The quality-of-life impact of prostate cancer treatments.

Authors:  Jaspreet Singh; Edouard J Trabulsi; Leonard G Gomella
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

6.  Anxiety and depression analyses of patients undergoing diagnostic cystoscopy.

Authors:  Stephan Seklehner; Paul Friedrich Engelhardt; Mesut Remzi; Harun Fajkovic; Zana Saratlija-Novakovic; Matthias Skopek; Irene Resch; Mario Duvnjak; Stephan Hruby; Clemens Wehrberger; Davor Librenjak; Wilhelm Hübner; Eckart Breinl; Claus Riedl
Journal:  Qual Life Res       Date:  2016-03-17       Impact factor: 4.147

7.  Development of anxiety and depression in patients with benign intracranial meningiomas: a prospective long-term study.

Authors:  Simone Goebel; H Maximilian Mehdorn
Journal:  Support Care Cancer       Date:  2012-12-14       Impact factor: 3.603

8.  The effect of disgust-related side-effects on symptoms of depression and anxiety in people treated for cancer: a moderated mediation model.

Authors:  Philip A Powell; Haffiezhah A Azlan; Jane Simpson; Paul G Overton
Journal:  J Behav Med       Date:  2016-03-07

9.  Pancreatic cancer and depression: myth and truth.

Authors:  Martina Mayr; Roland M Schmid
Journal:  BMC Cancer       Date:  2010-10-20       Impact factor: 4.430

10.  Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma.

Authors:  Jia Wang; Yueming Chen; Chunxiao Dai; Yushan Shang; Jian Xie
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.